SLC7A11 and neoplasm: The first evidence linking ferroptosis and tumors was the discovery that p53, a well-known tumor suppressor, sensitizes tumor cells to ferroptosis by inhibiting the expression of SLC7A11, a key component of the cystine/glutamate antiporter that mediates cystine transport and represses ROS-induced ferroptosis [8, 206–208].